Lexeo Therapeutics (LXEO) Operating Leases (2022 - 2023)
Historic Operating Leases for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $8.1 million.
- Lexeo Therapeutics' Operating Leases changed N/A to $8.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $8.1 million, marking a year-over-year change of. This contributed to the annual value of $9.0 million for FY2022, which is N/A changed from last year.
- Per Lexeo Therapeutics' latest filing, its Operating Leases stood at $8.1 million for Q3 2023.
- Lexeo Therapeutics' 5-year Operating Leases high stood at $9.0 million for Q4 2022, and its period low was $8.1 million during Q3 2023.